VC: PregLem gains $26M

VENTURE CAPITAL

COMPANY

AMOUNT/ROUND

LEAD INVESTORS

DESCRIPTION

PregLem [1]
Switzerland

$26M
First

Sofinnova Partners

PregLem has programs for gynecological conditions and infertility.

Kiadis Pharma [2]
Amsterdam

$20.16M

Alta Partners

Kiadis is developing therapies for bone marrow transplants and the treatment of aggressive cancers.